Immuneering Corporation(NASDAQ:IMRX) 
Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.
Website: https://immuneering.com/
Founded: 2008
CEO / Co-Founder: Ben Zeskind
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating expenses | ||||||||||||||||||||
research and development | 10,645,222 | 9,254,626 | 10,867,983 | 10,454,160 | 11,471,693 | 14,857,166 | 11,252,850 | 10,651,958 | 11,202,414 | 11,910,183 | 10,050,198 | 9,452,711 | 10,210,926 | 9,871,761 | 9,363,838 | 7,981,075 | 9,058,545 | 7,950,488 | 6,207,486 | 6,991,965 |
general and administrative | 4,682,495 | 4,490,776 | 4,505,406 | 4,296,417 | 4,005,642 | 3,693,672 | 4,013,581 | 4,254,473 | 4,116,019 | 4,384,488 | 3,868,823 | 4,044,960 | 4,461,331 | 4,106,385 | 3,836,032 | 3,704,143 | 3,951,866 | 3,148,637 | 2,598,940 | 1,340,398 |
amortization of intangible asset | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,317 | 7,316 | 7,317 | 7,317 | 8,103 | |||
total operating expenses | 15,335,034 | 13,752,719 | 15,380,706 | 14,757,894 | 15,484,652 | 18,558,155 | 15,273,748 | 14,913,748 | 15,325,750 | 16,301,988 | 13,926,338 | 13,504,988 | 14,679,574 | 13,985,462 | 13,207,187 | 11,692,535 | 13,018,514 | 11,099,125 | 8,806,426 | 8,332,363 |
income from operations | -15,335,034 | -13,752,719 | -15,380,706 | -14,757,894 | -15,484,652 | -18,558,155 | -15,273,748 | -14,913,748 | -15,325,750 | -16,301,988 | -13,926,338 | -13,504,988 | -14,679,574 | -13,985,007 | -13,188,150 | -11,646,049 | -12,925,662 | -11,115,755 | -8,543,384 | -7,990,924 |
yoy | -0.97% | -25.89% | 0.70% | -1.05% | 1.04% | 13.84% | 9.68% | 10.43% | 4.40% | 16.57% | 5.60% | 15.96% | 13.57% | 25.81% | 54.37% | 45.74% | ||||
qoq | 11.51% | -10.58% | 4.22% | -4.69% | -16.56% | 21.50% | 2.41% | -2.69% | -5.99% | 17.06% | 3.12% | -8.00% | 4.97% | 6.04% | 13.24% | -9.90% | 16.28% | 30.11% | 6.91% | |
operating margin % | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | NaN% | NaN% | NaN% | -3073627.91% | -34362.04% | -12334.43% | -7036.37% | -5863.02% | -1772.01% | -1210.67% |
other income | 513,735 | 91,430 | 129,310 | 7,717 | 213,037 | 464,352 | 475,595 | 150,193 | 244,129 | 223,278 | 120,835 | |||||||||
interest income | 1,360,404 | 1,861,044 | 415,831 | 324,013 | 438,520 | 415,240 | 547,072 | 826,104 | 804,884 | 754,144 | 855,532 | 1,166,047 | 831,274 | 516,168 | 222,985 | 142,799 | 132,506 | 142,885 | 17,400 | 3,259 |
net income | -13,460,895 | -11,580,010 | -14,964,875 | -14,433,881 | -15,046,132 | -18,051,485 | -14,597,366 | -14,079,927 | -14,307,829 | -15,083,492 | -12,595,211 | -12,188,748 | -13,604,171 | -13,245,561 | -12,844,330 | -11,527,303 | -12,896,374 | -10,784,359 | -8,534,073 | -7,987,665 |
yoy | -10.54% | -35.85% | 2.52% | 2.51% | 5.16% | 19.68% | 15.90% | 15.52% | 5.17% | 13.88% | -1.94% | 5.74% | 5.49% | 22.82% | 50.51% | 44.31% | ||||
qoq | 16.24% | -22.62% | 3.68% | -4.07% | -16.65% | 23.66% | 3.68% | -1.59% | -5.14% | 19.76% | 3.33% | -10.40% | 2.71% | 3.12% | 11.43% | -10.62% | 19.58% | 26.37% | 6.84% | |
net income margin % | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | NaN% | NaN% | NaN% | -2911112.31% | -33466.21% | -12208.67% | -7020.42% | -5688.22% | -1770.08% | -1210.18% |
net income per share | -0.21 | -0.07 | -0.38 | -0.4 | -0.42 | -0.59 | -0.49 | -0.47 | -0.49 | -0.52 | -0.43 | -0.43 | -0.51 | -0.5 | -0.49 | -0.44 | -0.49 | -0.05 | -0.47 | -1.61 |
weighted-average common shares outstanding, basic and diluted | 64,658,809 | 44,011,830 | 39,670,095 | 35,985,878 | 35,529,652 | 29,981,565 | 29,841,883 | 29,653,355 | 29,370,357 | 28,416,558 | 29,266,309 | 28,647,450 | 26,442,216 | 26,386,864 | 26,394,490 | 26,386,343 | 26,359,080 | 13,612,677 | 18,286,352 | 4,954,553 |
other comprehensive loss: | ||||||||||||||||||||
unrealized loss from marketable securities | -322,337 | |||||||||||||||||||
comprehensive loss | -13,783,232 | -11,498,678 | -14,964,875 | -14,433,881 | -15,046,132 | -18,059,331 | -14,589,521 | -14,078,843 | -14,308,135 | -15,089,877 | -12,587,386 | -12,191,472 | -13,573,545 | -13,133,208 | -12,805,242 | -11,541,469 | -13,014,760 | -10,828,617 | -8,538,824 | |
other comprehensive income: | ||||||||||||||||||||
unrealized gains from marketable securities | 2,156 | 7,845 | 1,084 | -306 | 8,931.75 | 7,825 | -2,724 | 30,626 | -23,366 | 39,088 | ||||||||||
revenue | 455 | 38,380 | 94,419 | 183,698 | 189,591 | 482,130 | 660,040 | |||||||||||||
yoy | NaN% | NaN% | NaN% | -99.76% | -92.04% | -85.69% | ||||||||||||||
qoq | NaN% | NaN% | NaN% | -98.81% | -59.35% | -48.60% | -3.11% | -60.68% | -26.95% | |||||||||||
cost of revenue | 19,343 | 47,933 | 90,846 | 206,221 | 219,088 | 318,601 | ||||||||||||||
gross profit | 455 | 19,037 | 46,486 | 92,852 | -16,630 | 263,042 | 341,439 | |||||||||||||
yoy | NaN% | NaN% | NaN% | -102.74% | -92.76% | -86.39% | ||||||||||||||
qoq | NaN% | NaN% | NaN% | -97.61% | -59.05% | -49.94% | -658.34% | -106.32% | -22.96% | |||||||||||
gross margin % | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | 100.00% | 49.60% | 49.23% | 50.55% | -8.77% | 54.56% | 51.73% |
other expense | -24,053 | -103,218 | -118,974 | -8,089 | ||||||||||||||||
unrealized losses from marketable securities | -14,166 | -118,386 | -44,258 | -4,751 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||
current assets: | ||||||||||||||||||||
cash and cash equivalents | 47,321,566 | 128,645,025 | 227,563,077 | 26,355,498 | 35,865,696 | 36,144,720 | 45,205,577 | 59,728,455 | 66,287,148 | 59,405,817 | 68,040,264 | 104,017,496 | 77,430,283 | 72,636,886 | 76,417,850 | 87,937,479 | 75,205,060 | 74,888,145 | 106,927,550 | 50,245,103 |
marketable securities | 109,372,057 | 5,452,155 | 4,991,200 | 42,550,420 | ||||||||||||||||
prepaids and other current assets | 4,715,535 | 3,414,685 | 1,538,752 | 1,369,928 | 2,340,459 | 3,442,849 | 4,601,769 | 3,957,220 | 3,169,089 | 3,417,984 | 3,340,248 | 2,521,757 | 2,696,640 | 3,209,536 | 2,757,220 | 890,409 | 1,479,592 | 2,888,608 | 3,361,471 | 696,684 |
total current assets | 161,409,158 | 176,245,954 | 229,101,829 | 27,725,426 | 38,206,155 | 39,587,569 | 55,259,501 | 63,685,675 | 74,447,437 | 89,083,669 | 100,582,760 | 111,507,093 | 94,233,529 | 108,746,809 | 120,024,690 | 129,170,188 | 139,530,219 | 152,333,996 | 153,310,816 | 51,436,892 |
marketable securities, non-current | 41,950,745 | 44,183,186 | 996,560 | 10,098,616 | ||||||||||||||||
property and equipment | 937,008 | 938,481 | 892,553 | 964,138 | 1,046,549 | 1,122,865 | 1,205,095 | 1,290,091 | 1,347,852 | 1,400,582 | 1,393,173 | 1,365,741 | 1,325,192 | 1,369,608 | 1,310,067 | 985,007 | 874,569 | 807,223 | 81,445 | 82,077 |
goodwill | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,690,431 | 6,701,726 | ||
intangible asset | 313,830 | 321,147 | 328,463 | 335,780 | 343,097 | 350,413 | 357,730 | 365,047 | 372,363 | 379,680 | 386,997 | 394,313 | 401,630 | 408,947 | 416,263 | 423,580 | 430,897 | 439,000 | ||
right-of-use assets | 3,230,489 | 3,322,249 | 3,411,693 | 3,498,967 | 3,584,170 | 3,667,352 | 3,748,565 | 3,827,943 | 3,905,575 | 3,995,730 | 4,083,875 | 4,194,049 | 4,301,999 | 4,407,785 | 4,512,883 | 4,691,157 | 4,831,639 | 5,324,198 | ||
other assets | 278,129 | 283,562 | 631,297 | 841,726 | 810,895 | 1,295,783 | 1,295,782 | 1,228,088 | 1,219,182 | 1,034,446 | 743,703 | 743,703 | 743,703 | 743,703 | 737,293 | 89,579 | 89,579 | 102,129 | 14,333 | 960,386 |
total assets | 214,809,790 | 231,985,010 | 241,056,266 | 40,056,468 | 50,681,297 | 52,714,413 | 68,557,104 | 77,087,275 | 87,982,840 | 102,584,538 | 113,880,939 | 124,895,330 | 107,696,484 | 122,367,283 | 133,691,627 | 142,049,942 | 152,447,334 | 166,704,832 | 164,042,391 | 53,042,125 |
liabilities and stockholders' equity | ||||||||||||||||||||
current liabilities: | ||||||||||||||||||||
accounts payable | 1,453,158 | 1,542,737 | 1,600,274 | 2,395,203 | 1,310,565 | 1,958,536 | 1,942,782 | 2,622,237 | 2,270,862 | 2,111,666 | 1,941,099 | 2,693,000 | 2,723,624 | 3,154,557 | 2,338,380 | 1,240,241 | 1,642,364 | 1,394,340 | 1,795,153 | 1,432,516 |
accrued expenses | 3,064,066 | 7,842,367 | 7,483,142 | 4,514,960 | 3,388,562 | 4,973,129 | 4,592,825 | 3,757,148 | 2,584,359 | 5,173,960 | 3,299,053 | 2,426,899 | 2,412,413 | 4,500,993 | 4,564,136 | 2,226,687 | 1,718,804 | 3,965,447 | 3,388,853 | 3,318,870 |
other liabilities | 44,191 | 291,513 | 80,089 | 209,708 | 56,531 | 233,665 | 59,657 | 90,242 | 23,634 | 259,770 | ||||||||||
lease liabilities | 412,835 | 397,104 | 381,760 | 366,959 | 352,521 | 338,438 | 324,702 | 311,459 | 298,543 | 300,107 | ||||||||||
total current liabilities | 4,974,250 | 10,073,721 | 9,545,265 | 7,486,830 | 5,108,179 | 7,503,768 | 6,919,966 | 6,781,086 | 5,177,398 | 7,845,503 | 5,622,282 | 5,478,907 | 5,525,608 | 8,054,069 | 7,255,772 | 3,800,515 | 3,673,800 | 5,633,826 | 5,266,801 | 4,831,991 |
long-term liabilities: | ||||||||||||||||||||
lease liabilities, net of current portion | 3,317,369 | 3,427,321 | 3,534,569 | 3,633,601 | 3,730,198 | 3,824,419 | 3,916,324 | 4,000,554 | 4,082,713 | 4,162,852 | ||||||||||
total liabilities | 8,291,619 | 13,501,042 | 13,079,834 | 11,120,431 | 8,838,377 | 11,328,187 | 10,836,290 | 10,781,640 | 9,260,111 | 12,008,355 | 9,863,302 | 9,790,915 | 9,906,860 | 12,517,028 | 11,798,425 | 8,455,096 | 8,391,224 | 10,724,723 | 5,748,766 | 5,335,204 |
commitments and contingencies | ||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||
preferred stock, 0.001 par value... | ||||||||||||||||||||
class a common stock, 0.001 par value... | 64,689 | 64,648 | 63,483 | 35,987 | 35,985 | 31,050 | 31,050 | 29,653 | 29,653 | 29,272 | 29,269 | 29,263 | 26,496 | 26,419 | 26,405 | 26,392 | 26,383 | 26,320 | 25,938 | 5,276 |
class b common stock, 0.001 par value... | ||||||||||||||||||||
additional paid-in capital | 500,475,466 | 498,658,072 | 496,653,023 | 282,675,249 | 281,148,253 | 265,650,362 | 263,925,619 | 257,922,316 | 256,260,567 | 253,806,267 | 252,157,847 | 250,657,245 | 221,153,749 | 219,640,912 | 218,550,665 | 217,447,080 | 216,366,884 | 215,276,186 | 206,761,467 | 4,763,900 |
accumulated other comprehensive income | -241,005 | 81,332 | 5,607 | |||||||||||||||||
accumulated deficit | -293,780,979 | -280,320,084 | -268,740,074 | -253,775,199 | -239,341,318 | -224,295,186 | -206,243,700 | -191,646,334 | -177,566,407 | -163,258,578 | -148,175,086 | -135,579,875 | -123,391,127 | -109,786,956 | -96,541,395 | -83,697,065 | -72,169,762 | -59,273,388 | -48,489,029 | -39,954,956 |
total stockholders' equity | 206,518,171 | 218,483,968 | 227,976,432 | 28,936,037 | 41,842,920 | 41,386,226 | 57,720,814 | 66,305,635 | 78,722,729 | 90,576,183 | 104,017,637 | 115,104,415 | 97,789,624 | 109,850,255 | 121,893,202 | 133,594,846 | 144,056,110 | 155,980,109 | 158,293,625 | |
total liabilities and stockholders' equity | 214,809,790 | 231,985,010 | 241,056,266 | 40,056,468 | 50,681,297 | 52,714,413 | 68,557,104 | 77,087,275 | 87,982,840 | 102,584,538 | 113,880,939 | 124,895,330 | 107,696,484 | 133,691,627 | 142,049,942 | 152,447,334 | ||||
marketable securities, current | 44,186,244 | 26,259,868 | 29,202,248 | 4,967,840 | 14,105,560 | 32,887,970 | 40,779,440 | 40,163,875 | 62,565,953 | 74,311,203 | ||||||||||
accumulated other comprehensive loss | 7,845 | -1,084 | -778 | -2,218 | -30,120 | -142,473 | -181,561 | -167,395 | -49,009 | -4,751 | ||||||||||
accounts receivable | 1,046 | 12,417 | 70,180 | 178,425 | 279,614 | 246,040 | 471,375 | 495,105 | ||||||||||||
other liabilities, current | 80,497 | 26,333 | 26,333 | 19,796 | 44,562 | 47,213 | 47,213 | |||||||||||||
lease liabilities, current | 301,633 | 332,675 | 363,238 | 378,723 | 308,694 | 286,374 | 265,419 | 274,039 | ||||||||||||
lease liabilities, non-current | 4,241,020 | 4,312,008 | 4,381,252 | 4,462,959 | 4,542,653 | 4,644,683 | 4,707,526 | 5,090,897 | ||||||||||||
accumulated other comprehensive gain | 506 | |||||||||||||||||||
liabilities, convertible preferred stock and stockholders' equity | ||||||||||||||||||||
total liabilities, convertible preferred stock and stockholders' equity | 122,367,283 | 166,704,832 | 164,042,391 | |||||||||||||||||
other liabilities, non-current | 9,898 | 9,898 | ||||||||||||||||||
convertible preferred stock: | ||||||||||||||||||||
series b preferred stock, 0.001 par value... | 61,772,761 | |||||||||||||||||||
series a preferred stock, 0.001 par value... | 21,119,940 | |||||||||||||||||||
total convertible preferred stock | 82,892,701 | |||||||||||||||||||
stockholders’ deficit: | ||||||||||||||||||||
right-of-use asset | 537,181 | 562,770 | ||||||||||||||||||
liabilities, convertible preferred stock and stockholders' deficit | ||||||||||||||||||||
lease liability, current | 82,795 | 80,605 | ||||||||||||||||||
lease liability, non-current | 481,965 | |||||||||||||||||||
lease liability, noncurrent | 503,213 | |||||||||||||||||||
total stockholders' deficit | -35,185,780 | |||||||||||||||||||
total liabilities, convertible preferred stock and stockholders' deficit | 53,042,125 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||
net loss | -13,460,895 | -11,580,010 | -14,964,876 | -14,433,880 | -15,046,132 | -18,051,485 | -14,597,367 | -14,079,927 | -14,307,829 | -15,083,492 | -12,595,212 | -12,188,747 | -13,604,171 | -37,268,007 | -24,423,677 | -12,896,374 | -22,751,389 | -14,217,316 |
adjustment to reconcile to net loss to net cash from operating activities: | ||||||||||||||||||
depreciation and amortization expense | 81,402 | 75,889 | 78,840 | 84,527 | 85,261 | |||||||||||||
reduction in carrying amount of right-of-use assets | 91,760 | 89,443 | 87,274 | 85,203 | 83,183 | 81,212 | 79,378 | 77,632 | 90,155 | 88,145 | 110,173 | |||||||
intangible asset amortization | 7,317 | 7,317 | 7,316 | 7,317 | 7,317 | 7,316 | 7,317 | 7,317 | 7,316 | 7,317 | 22,737 | 15,420 | 8,103 | |||||
stock-based compensation expense | 1,636,675 | 1,637,845 | 1,456,080 | 1,524,943 | 1,692,267 | 1,724,743 | 1,640,116 | 1,661,749 | 1,474,758 | 1,640,588 | 1,479,160 | |||||||
net accretion of discount on marketable securities | -404,723 | -55,690 | -34,140 | -7,712 | -161,639 | |||||||||||||
change in assets and liabilities: | ||||||||||||||||||
decrease in: | ||||||||||||||||||
prepaid expenses and other current assets | -1,180,990 | -1,412,260 | -168,824 | 970,530 | 1,102,391 | 1,158,920 | -644,549 | -788,131 | 248,895 | -41,948 | -818,491 | 174,883 | 512,896 | 166,413 | 2,026,298 | 1,409,016 | -3,122,547 | -555,726 |
other assets | 5,434 | 311,397 | 348,790 | -94,844 | 548,902 | 0 | -67,693 | -223,644 | 30,000 | -356,117 | 12,550 | 12,550 | -946,053 | |||||
increase in: | ||||||||||||||||||
accounts payable | -89,579 | 73,415 | -974,893 | 1,188,550 | -687,871 | 56,741 | -679,454 | 393,177 | 117,393 | 170,568 | -778,202 | -68,329 | -430,933 | 944,040 | -154,099 | 248,022 | 314,616 | -48,021 |
accrued expenses | -4,778,301 | 990,501 | 2,366,906 | 1,150,513 | -1,608,683 | 380,304 | 835,677 | 1,345,722 | -2,762,534 | 1,946,205 | 849,878 | 19,269 | -2,093,363 | 385,536 | -1,727,466 | -2,235,349 | 2,689,860 | 2,619,878 |
lease liabilities | -94,221 | -91,904 | -84,230 | -82,159 | -80,139 | -78,168 | -70,988 | -69,243 | -81,703 | -79,694 | ||||||||
other liabilities | -247,323 | 211,424 | -129,619 | 153,177 | -177,134 | 174,008 | -30,585 | 66,608 | -236,136 | 179,273 | 54,164 | 0 | 6,537 | 44,562 | 57,111 | 57,112 | ||
net cash from operating activities | -18,433,444 | -9,840,598 | -11,977,235 | -9,446,124 | -14,080,638 | -14,510,513 | -13,472,024 | -11,525,920 | -15,491,114 | -11,775,201 | -12,026,932 | -10,748,483 | -14,418,018 | -32,352,651 | -21,730,312 | -12,281,039 | -21,611,892 | -12,577,263 |
capital expenditures | -79,930 | -123,910 | -7,255 | -2,116 | -8,945 | -9,356 | -5,268 | -32,773 | -37,478 | -170,918 | -57,149 | -86,686 | -27,993 | -673,181 | -280,047 | -115,050 | -47,734 | -36,388 |
free cash flows | -18,513,374 | -9,964,508 | -11,984,490 | -9,448,240 | -14,089,583 | -14,519,869 | -13,477,292 | -11,558,693 | -15,528,592 | -11,946,119 | -12,084,081 | -10,835,169 | -14,446,011 | -33,025,832 | -22,010,359 | -12,396,089 | -21,659,626 | -12,613,651 |
cash flows from investing activities: | ||||||||||||||||||
purchases of property and equipment | -79,930 | -123,910 | -7,255 | -2,116 | -8,945 | -9,356 | -5,268 | -32,773 | -37,478 | -170,918 | -57,149 | -86,686 | -27,993 | -673,181 | -280,047 | -115,050 | -47,734 | |
purchases of marketable securities | -71,990,845 | 0 | -15,746,163 | -37,726,144 | -17,989,202 | -7,980,107 | -52,760,299 | |||||||||||
maturities of marketable securities | 9,000,000 | 5,500,000 | 0 | 5,000,000 | 21,430,000 | 19,050,000 | 5,000,000 | 9,250,000 | 19,000,000 | 72,078,000 | 52,828,000 | 20,500,000 | ||||||
net cash from investing activities | -63,070,775 | -88,719,931 | -7,255 | -2,116 | -8,945 | 5,490,644 | -5,415,438 | 4,967,227 | 21,392,522 | 3,132,919 | -23,971,748 | 9,163,314 | 18,972,007 | 33,678,675 | 34,558,751 | 12,404,843 | -52,808,033 | -36,388 |
cash flows from financing activities: | ||||||||||||||||||
proceeds from exercise of stock options | 10,435 | 229,832 | 136,645 | 0 | 0 | 0 | 732,458 | 7,835 | 21,448 | 176,147 | 239,408 | 258,281 | 220,895 | 193,111 | 346,915 | 52,627 | ||
proceeds from issuance of common stock under employee stock purchase plan | 170,325 | 288,018 | 0 | 133,892 | ||||||||||||||
proceeds from issuance of common stock under at-the-market offering, net of issuance costs | ||||||||||||||||||
net cash from financing activities | 180,760 | -357,523 | 213,192,069 | -61,958 | 13,810,559 | -40,988 | 4,364,584 | 0 | 979,923 | 7,835 | 21,448 | 28,172,382 | 239,408 | 203,681 | 220,895 | 193,111 | 144,257,324 | 25,768,603 |
net decrease in cash and cash equivalents | -81,323,459 | -9,060,857 | ||||||||||||||||
cash and cash equivalents at beginning of period | 128,645,025 | 0 | 0 | 0 | 36,144,720 | 0 | 0 | 0 | 59,405,817 | 0 | 0 | 0 | 72,636,886 | 74,888,145 | 74,888,145 | 74,888,145 | 37,090,151 | 37,090,151 |
cash and cash equivalents at end of period | 47,321,566 | -98,918,052 | 201,207,579 | -9,510,198 | 35,865,696 | -9,060,857 | -14,522,878 | -6,558,693 | 66,287,148 | -8,634,447 | -35,977,232 | 26,587,213 | 77,430,283 | 76,417,850 | 87,937,479 | 75,205,060 | 106,927,550 | 50,245,103 |
supplemental disclosures of noncash information: | ||||||||||||||||||
deferred offering costs included in accounts payable and accrued expenses | 64,015 | 224,448 | 875,078 | |||||||||||||||
amortization of intangibles | ||||||||||||||||||
loss on disposal of fixed assets | 5,469 | 2,456 | 0 | 817 | 666 | |||||||||||||
payment of offering costs | 0 | -54,600 | ||||||||||||||||
proceeds from issuance of common stock under atm, net of offering expenses | ||||||||||||||||||
proceeds from employee stock purchase plan | 0 | 247,465 | ||||||||||||||||
issuance of common stock through public offering, net of commissions and underwriting discounts | ||||||||||||||||||
issuance of common stock through private placement with aventis inc. | ||||||||||||||||||
proceeds from sale of common stock, prefunded warrants and common stock warrants | ||||||||||||||||||
net increase in cash and cash equivalents | -98,918,052 | 201,207,579 | -9,510,198 | -279,024 | -6,558,693 | 6,881,331 | -35,977,232 | 26,587,213 | 4,793,397 | 1,529,705 | 13,049,334 | 316,915 | 69,837,399 | 13,154,952 | ||||
supplemental disclosures of noncash investing and financing information: | ||||||||||||||||||
deferred offering costs in accounts payable/accrued expenses | ||||||||||||||||||
cashless exercise of prefunded warrants | ||||||||||||||||||
proceeds from sale of common stock, prefunded warrants and common stock warrants through private placement | ||||||||||||||||||
proceeds from public offering of common stock, net of commissions and underwriting | 0 | 0 | ||||||||||||||||
proceeds from issuance of common stock through private placement with aventis inc | ||||||||||||||||||
payment of offering and placement costs | ||||||||||||||||||
offering and placement costs included in accounts payable/accrued expenses | ||||||||||||||||||
proceeds from issuance of common stock under at-the-market offering, net of offering expenses | 0 | 13,676,667 | ||||||||||||||||
depreciation expense | 76,527 | 170,337 | 102,263 | 47,704 | 30,652 | 18,674 | ||||||||||||
accounts receivable | 0 | 0 | 1,046 | 11,371 | 175,860 | 67,615 | -33,573 | 28,735 | 5,005 | |||||||||
payment of public offering costs | ||||||||||||||||||
property and equipment in accounts payable/accrued expenses | -71,299 | 48,577 | 32,921 | 4,784 | ||||||||||||||
depreciation/amortization expense | 88,949 | 90,533 | 90,209 | 78,294 | ||||||||||||||
deferred offering costs included in accounts payable/accrued expenses | 214,736 | |||||||||||||||||
reduction of right-of-use asset and lease liability in connection with lease modification | ||||||||||||||||||
net amortization of premium (accretion of discount) on marketable securities | -311,984 | 144,441 | 103,531 | 8,548 | ||||||||||||||
lease liability | -99,808 | -97,192 | -116,718 | -86,141 | -44,252 | -56,329 | -37,271 | |||||||||||
reduction in carrying amount of right-of-use asset | 105,786 | |||||||||||||||||
stock based compensation expense | 1,273,505 | 3,016,283 | 1,950,071 | 897,650 | 1,170,040 | 533,234 | ||||||||||||
net amortization of premium (discount) on marketable securities | -186,964 | |||||||||||||||||
right-of-use asset amortization | 414,444 | 285,302 | 144,821 | 75,922 | 50,333 | |||||||||||||
deferred tax benefit | ||||||||||||||||||
cash acquired in business combination | ||||||||||||||||||
proceeds from the issuance of series b preferred stock, net of issuance costs | 24,788,851 | 24,788,851 | ||||||||||||||||
proceeds from initial public offering of common stock, net of commissions and underwriting | 120,318,750 | |||||||||||||||||
payment of initial public offering costs | -2,124,317 | |||||||||||||||||
proceeds from exercise of warrants | 927,125 | 927,125 | ||||||||||||||||
conversion of convertible series a and b preferred stock into common stock | 82,892,701 | |||||||||||||||||
business combination non-cash | ||||||||||||||||||
class a common stock issued for business combination | ||||||||||||||||||
net amortization of premium on marketable securities | 47,979 | |||||||||||||||||
reduction of right of use asset and lease liability in connection with lease modification | 396,901 | 347,739 | 347,739 | |||||||||||||||
proceeds from the issuance of series a preferred stock, net of issuance costs | ||||||||||||||||||
business combination non cash | ||||||||||||||||||
reclassification of liability for series a preferred stock | ||||||||||||||||||
purchase of property and equipment | -36,388 |